You are here: Home / News & Events / News / A Day of Dialogue on Rare Diseases and Orphan Products

A Day of Dialogue on Rare Diseases and Orphan Products

The NORD Corporate Council met on May 17 in Washington DC for "A Day of Dialogue" with FDA senior staff and other key opinion leaders.

The NORD Corporate Council met on May 17 in Washington DC for "A Day of Dialogue" with FDA senior staff and other key opinion leaders.  Read about the Corporate Council.

cc-2011-fda

FDA Representatives from left to right: Michelle McMurry-Heath, Theresa Mullin, Larry Bauer, Nisha Jain, Anne Pariser and Tim Cote

cc-2011-yann

Yann Le Cam, Chief Executive Office, Rare Diseases Europe (EURORDIS)

cc-2011-austin

Christopher Austin, MD, Director, Center for Translational Therapeutics, NIH

cc-2011-nord

NORD staff members from left to right: Mary Dunkle, Peter Saltonstall, Diane Dorman, Mike Scott, Mary Cobb, Pamela Gavin, and Frank Sasinowski.

 
Copyright ©2014 NORD - National Organization for Rare Disorders, Inc. All rights reserved.
The following trademarks/registered service marks are owned by NORD: NORD, National Organization for Rare Disorders, the NORD logo, RareConnect. .